Non-severe COVID-19 complicated by cytotoxic lesions of the corpus callosum (mild encephalitis/encephalopathy with a reversible splenial lesion): a case report and literature review

[1]  Karl A. Soetebier,et al.  Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods — United States, December 2020–January 2022 , 2022, MMWR. Morbidity and mortality weekly report.

[2]  F. Scorza,et al.  Letter to the Editor: Ischemic Stroke of the Corpus Callosum after SARS-CoV-2 Vaccination , 2021, Journal of Korean medical science.

[3]  B. Kara,et al.  Cytotoxic lesions of the corpus callosum in children: Etiology, clinical and radiological features, and prognosis , 2021, Brain and Development.

[4]  S. Wen,et al.  COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2 , 2021, Journal of Neurology.

[5]  E. Moro,et al.  Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium , 2021, JAMA network open.

[6]  M. Thurnher,et al.  Distinct pattern of microsusceptibility changes on brain magnetic resonance imaging (MRI) in critically ill patients on mechanical ventilation/oxygenation , 2021, Neuroradiology.

[7]  Y. Balcioglu,et al.  SARS-CoV-2-associated first episode of acute mania with psychotic features , 2021, Journal of Clinical Neuroscience.

[8]  Biyan Nathanael Harapan,et al.  Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) , 2021, Journal of Neurology.

[9]  R. Fumagalli,et al.  Neurological manifestations in patients hospitalized with COVID‐19: A retrospective analysis from a large cohort in Northern Italy , 2020, The European journal of neuroscience.

[10]  R. Lenthall,et al.  Letter by Dhillon and Lenthall Regarding Article, "Infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time". , 2020, Stroke.

[11]  P. Bieri,et al.  Response by Sparr and Bieri to Letter Regarding Article, "Infarction of the Splenium of the Corpus Callosum in the Age of COVID-19: A Snapshot in Time". , 2020, Stroke.

[12]  N. Akhtar,et al.  A 23-Year-Old Man with SARS-CoV-2 Infection Who Presented with Auditory Hallucinations and Imaging Findings of Cytotoxic Lesions of the Corpus Callosum (CLOCC) , 2020, The American journal of case reports.

[13]  V. Sawlani,et al.  COVID-19-related intracranial imaging findings: a large single-centre experience , 2020, Clinical Radiology.

[14]  P. Gaur,et al.  COVID-19-Associated Cytotoxic Lesions of the Corpus Callosum , 2020, American Journal of Neuroradiology.

[15]  J. Maldjian,et al.  Neurological emergencies associated with COVID-19: stroke and beyond , 2020, Emergency Radiology.

[16]  A. Krishnan,et al.  COVID-19 and Involvement of the Corpus Callosum: Potential Effect of the Cytokine Storm? , 2020, American Journal of Neuroradiology.

[17]  J. Finnsson,et al.  Nervous System Involvement in COVID-19: Results from a Retrospective Consecutive Neuroimaging Cohort , 2020, Radiology.

[18]  S. Lehéricy,et al.  Retrospective Observational Study of Brain Magnetic Resonance Imaging Findings in Patients with Acute SARS-CoV-2 Infection and Neurological Manifestations , 2020, Radiology.

[19]  D. Pugin,et al.  COVID‐19 is Associated with an Unusual Pattern of Brain Microbleeds in Critically Ill Patients , 2020, Journal of Neuroimaging.

[20]  D. Pugin,et al.  Unusual Microbleeds in Brain MRI of Covid-19 Patients. , 2020, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[21]  U. Löbel,et al.  Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. , 2020, JAMA neurology.

[22]  T. Shimohata,et al.  COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion , 2020, Journal of the Neurological Sciences.

[23]  N. Agarwal,et al.  Unusual lesion in the splenium of the corpus callosum and coronavirus infectious disease-19 , 2020, BJR case reports.

[24]  N. Enomoto,et al.  A first case of meningitis/encephalitis associated with SARS-Coronavirus-2 , 2020, International Journal of Infectious Diseases.

[25]  X. Sun,et al.  Clinical, neuroimaging and prognostic study of 127 cases with infarction of the corpus callosum , 2019, European journal of neurology.

[26]  Wenli Hu,et al.  Mild encephalitis/encephalopathy with reversible splenial lesion (MERS) in adults-a case report and literature review , 2017, BMC Neurology.

[27]  Yuji Numaguchi,et al.  Cytotoxic Lesions of the Corpus Callosum That Show Restricted Diffusion: Mechanisms, Causes, and Manifestations. , 2017, Radiographics : a review publication of the Radiological Society of North America, Inc.

[28]  Ling Zhang,et al.  Reversible splenial lesion syndrome associated with encephalitis/encephalopathy presenting with great clinical heterogeneity , 2016, BMC Neurology.

[29]  A. Berkowitz,et al.  Reversible splenial lesion syndrome , 2015, Practical Neurology.

[30]  J. Takanashi,et al.  Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes , 2012, Brain and Development.

[31]  Juan Carlos Garcia-Monco,et al.  Reversible Splenial Lesion Syndrome (RESLES): What's in a Name? , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[32]  T. Taoka,et al.  Clinically mild encephalitis/encephalopathy with a reversible splenial lesion , 2004, Neurology.

[33]  A J Barkovich,et al.  Clinically mild encephalitis/encephalopathy with a reversible splenial lesion , 2004, Neurology.